Treatment of Traumatic Direct Carotid-Cavernous Fistula with a BeGraft-Covered Stent.

Autor: Seraj FQM; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran., Najafi S; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Neurosurgery, Emam Hospital, Mazandaran University of Medical Sciences, School of Medicine, Sari, Iran., Raaisi AA; Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France., Mirbolouk MH; Department of Neurosurgery, Firouzgar Hospital, Iran University of Medical Sciences, School of Medicine, Tehran, Iran., Ebrahimnia F; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran., Shamsi HP; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran., Garivani Y; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran., Zabihyan S; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran., Mowla A; Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA., Baharvahdat H; Department of Neurosurgical, Section of Neurovascular, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France.
Jazyk: angličtina
Zdroj: Neurointervention [Neurointervention] 2024 Jul; Vol. 19 (2), pp. 111-117. Date of Electronic Publication: 2024 May 30.
DOI: 10.5469/neuroint.2024.00157
Abstrakt: The widely accepted option for treating traumatic direct carotid-cavernous fistula (dCCF) has been endovascular treatment using detachable balloons, coils, or embolic agents. Covered stent deployment has been applied by a few operators and has shown promising results. This is a retrospective study on patients with dCCF treated by an endovascular approach using BeGraft, a covered stent. In 4 cases, this device was successfully deployed without any complications. Immediate complete occlusion was achieved in 3 patients (75%) after deployment of the covered stents. One patient required transvenous coiling for occlusion of the remaining endoleak. Follow-up imaging demonstrated 100% fistula occlusion with complete internal carotid artery patency. No early or late complications occurred following treatment. In conclusion, the BeGraft-covered stent could be a promising safe and effective alternative option for the endovascular treatment of dCCF.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje